Mostrando 2 resultados de: 2
Atherogenic dyslipidemia in Latin America: Prevalence, causes and treatment. Consensus
ReviewAbstract: Atherogenic dyslipidemia (DA) is a poorly recognized entity in the current clinical practice guideliPalabras claves:Atherogenic dyslipidemia, Highdensity lipoprotein, Low-density lipoprotein, Practical recommendations, TriglyceridesAutores:Acevedo M., Bryce A., Carrera C., Gómez-Mancebo J.R., Isea-Perez J.E., Lanas F.T., Lorenzatti A.J., Lozada A.F., Machado L., Medina J., Morales E., PATRICIO LOPEZ -JARAMILLO, Pinto X., Pirskorz D., Ponte-Negretti C.I., Wyss-Quintana F.S.Fuentes:googlescopusThe Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives
ArticleAbstract: Hypertension is a major risk factor for the development of heart failure with preserved ejection fraPalabras claves:Autores:Adeseye A., Barroso W.S., Camafort-Babkowski M., Coca A., Damasceno A., De Simone G., Dorobantu M., Jhund P.S., Kario K., Komori T., Lee H.y., Ogah O.S., Padmanabahn S., Pascual-Figal D.A., PATRICIO LOPEZ -JARAMILLO, Pyun W.B., Renna N.F., Valdez-Tiburcio O., Wyss-Quintana F.S.Fuentes:googlescopus